Neurocrine Biosciences, Inc. (NBIX)
141.83
+0.88
(+0.62%)
USD |
NASDAQ |
Dec 31, 16:00
141.80
-0.04
(-0.02%)
After-Hours: 20:00
Neurocrine Biosciences Free Cash Flow: 593.10M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Masimo Corp. | 188.70M |
| Insulet Corp. | 407.70M |
| Marker Therapeutics, Inc. | -14.82M |
| CapsoVision, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 227.50M |
| Cash from Investing (Quarterly) | -196.70M |
| Cash from Financing (Quarterly) | 45.60M |
| Free Cash Flow Per Share (Quarterly) | 2.091 |
| Free Cash Flow to Equity (Quarterly) | 224.40M |
| Free Cash Flow to Firm (Quarterly) | 214.30M |
| Free Cash Flow Yield | 4.09% |